Earnings season can be cuckoo season. The forecasts get cut, but the faith stays full price. A fund manager recently quipped on X that, at this rate, the sell side might as well publish 2049 earnings estimates and target prices. In short, give a recovery enough calendar space and today’s valuation could eventually look reasonable.

The joke raises a question about how analysts respond to disappointing earnings. When they cut their profit forecasts, should they also reconsider the valuation multiple, or does the business still deserve the same price for each rupee it is expected to earn?

A target price calculated using a price-to-earnings, or P/E, multiple depends on three choices. The earnings forecast estimates the profit a company might generate, the multiple expresses what the analyst considers appropriate to pay for it, and the reference period determines which forecast enters the calculation. Revising any of these can change the target.

A recent research update for Hyundai Motor India did just that. The broker reduced earnings-per-share estimates for three financial years by roughly 5–8%, retained its stated 26-times valuation framework and moved the earnings reference period forward. The target price fell from ₹2,327 to ₹2,209. 

Retaining the multiple may be reasonable if the setback leaves the company’s growth prospects, returns and risks largely unchanged. The report offers a recovery case through higher capacity utilisation, localisation, a better product mix and stronger exports. Its detailed forecasts envisage EBITDA margins reaching 12.4% and 13.3% in 2027-28 and 2028-29, respectively. 

The justification depends on how much those improvements contribute and when they materialise. Investors should be able to identify the assumptions essential to the retained multiple. A statement that the long-term outlook remains intact needs to explain why weaker earnings expectations do not alter that assessment.

In another report, the same brokerage cuts the multiple. Faced with weaker operating expectations at eClerx Services, it reduced its target P/E from 17.6 times to 16.9 times by lowering the premium assigned over its benchmark. It cited slower client decisions, weaker growth and an eight-quarter low in annual contract value. 

The contrast raises a more useful question than whether analysts are habitually optimistic. What distinguishes a disappointment that changes only the profit forecast from one that also changes the multiple?

A setback that postpones earnings is different from evidence that those earnings may be harder to generate. Weaker pricing power, persistent competition or lower returns on investment can affect the assumptions supporting a premium. Where a downgrade reveals such problems, reducing the earnings forecast alone may not fully reflect the deterioration.

The earnings reference period matters too. A report on Grindwell Norton raised earnings estimates modestly and reduced its target multiple from 41 times to 40 times. Yet the target price increased from ₹2,113 to ₹2,245, alongside a move in the reference period from March 2028 to September 2028. 

This was not an earnings-downgrade case. It shows how earnings upgrades and a later valuation period can outweigh a reduction in the multiple, producing a higher target price.

Rolling a valuation forward is a legitimate part of updating research. If the later period carries higher expected earnings, however, the change can support the target price without an upward revision to the forecasts themselves. Readers need to see that contribution separately before judging whether the revised target reflects a better business outlook.

The earlier column on the stain theory of investing examined how setbacks become reassuring stories. The valuation question follows from it. Explaining an earnings miss does not establish why the multiple should remain unchanged, particularly when the explanation asks investors to wait longer for recovery.

A delay need not invalidate the investment case, but investors should assess whether the prospective return still compensates them for the additional time and uncertainty. A more distant earnings forecast does not resolve that question.

A clear bridge between the old target price and the new one would help. It should separate the effects of earnings revisions, changes to the multiple and a later reference period, along with any other material adjustments. That would let readers distinguish a changed assessment of the business from an update to the calculation.

Analysts should also identify the operating milestones supporting their valuation and when they expect them to appear. Better margins, stronger cash generation or improved returns provide grounds for retaining confidence, but missing those milestones should prompt a reassessment.

Not every earnings downgrade requires a derating. What matters is consistency in how the multiple is justified. If stronger growth supports a higher multiple, evidence of weaker growth should reopen the discussion.

Investors can give a business time to recover while questioning what they should pay for that recovery. Before accepting the revised target, they should know what would make the analyst assign a lower multiple to the expected earnings